GHS is an international consulting firm with a portfolio of clients from the public, private and not-for-profit sectors. Working with many of the world’s foremost health organizations, GHS' past and current clients include amfAR, the International Partnership for Microbicides, the Rockefeller Foundation, Aeras Global TB Vaccine Foundation, the Bill & Melinda Gates Foundation, GlaxoSmithKline Biologicals, QIAGEN and the Michael and Susan Dell Foundation. GHS has a strong background in the areas of communications, resource mobilization, research and policy analysis, advocacy, and strategic development.
Founded in 1985, amfAR is dedicated to ending the global AIDS epidemic through innovative research.
The Aeras Global TB Vaccine Foundation is a non-profit Product Development Partnership (PDP) dedicated to the development of effective TB vaccine regimens that will prevent tuberculosis in all age groups and will be affordable, available and adopted worldwide.
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives.
IPM is a non-profit product development partnership (PDP) established in 2002 to prevent HIV transmission by accelerating the development and availability of a safe and effective microbicide for use by women in developing countries.
Michael & Susan Dell Foundation works to improve outcomes for children around the world in a measurable way. Established in 1999 with a gift from Michael and Susan Dell, the foundation uses its endowment of more than US$1 billion to address issues facing children living in urban poverty.
QIAGEN is the leading provider of sample and assay technologies. Sample technologies are used to isolate DNA, RNA and proteins from any biological sample.
The work of the Rockefeller Foundation for the 21st Century is to enable 'smart globalization.' It attempts to harness the creative forces of globalization to ensure that the tools and technologies that have significantly improved the human condition in many parts of the world during the past half century are accessible today to more people, more fully, in more places.
Women Deliver is a global advocacy organization bringing together voices from around the world to call for action against maternal death.
Zyomyx, Inc. is a biotechnology company focused on developing affordable, disposable point-of-care diagnostic products designed to increase access to testing. This includes the company’s CD4 T-cell test, created specifically for use in developing countries, which provides critical information regarding HIV treatment initiation and monitoring.